Frank Rimerman Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515K | Buy |
981
+67
| +7% | +$35.2K | 0.03% | 343 |
|
|
2025
Q1 | $580K | Buy |
914
+390
| +74% | +$247K | 0.05% | 286 |
|
|
2024
Q4 | $373K | Sell |
524
-73
| -12% | -$52K | 0.03% | 370 |
|
|
2024
Q3 | $628K | Buy |
597
+20
| +3% | +$21K | 0.04% | 291 |
|
|
2024
Q2 | $606K | Buy |
577
+574
| +19,133% | +$603K | 0.04% | 302 |
|
|
2024
Q1 | $2.89K | Hold |
3
| – | – | ﹤0.01% | 255 |
|
|
2023
Q4 | $2.64K | Buy |
+3
| New | +$2.64K | ﹤0.01% | 249 |
|